209 related articles for article (PubMed ID: 32622856)
21. Crystal structures of the free and ligand-bound FK1-FK2 domain segment of FKBP52 reveal a flexible inter-domain hinge.
Bracher A; Kozany C; Hähle A; Wild P; Zacharias M; Hausch F
J Mol Biol; 2013 Nov; 425(22):4134-44. PubMed ID: 23933011
[TBL] [Abstract][Full Text] [Related]
22. FKBPs in chromatin modification and cancer.
Yao YL; Liang YC; Huang HH; Yang WM
Curr Opin Pharmacol; 2011 Aug; 11(4):301-7. PubMed ID: 21489876
[TBL] [Abstract][Full Text] [Related]
23. FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition.
Baughman G; Wiederrecht GJ; Campbell NF; Martin MM; Bourgeois S
Mol Cell Biol; 1995 Aug; 15(8):4395-402. PubMed ID: 7542743
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.
Sigal NH; Dumont FJ
Annu Rev Immunol; 1992; 10():519-60. PubMed ID: 1375473
[TBL] [Abstract][Full Text] [Related]
25. A novel plant peptidyl-prolyl-cis-trans-isomerase (PPIase): cDNA cloning, structural analysis, enzymatic activity and expression.
Blecher O; Erel N; Callebaut I; Aviezer K; Breiman A
Plant Mol Biol; 1996 Nov; 32(3):493-504. PubMed ID: 8980498
[TBL] [Abstract][Full Text] [Related]
26. The FKBP-type domain of the human aryl hydrocarbon receptor-interacting protein reveals an unusual Hsp90 interaction.
Linnert M; Lin YJ; Manns A; Haupt K; Paschke AK; Fischer G; Weiwad M; Lücke C
Biochemistry; 2013 Mar; 52(12):2097-107. PubMed ID: 23418784
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective and antioxidant properties of FKBP-binding immunophilin ligands are independent on the FKBP12 pathway in human cells.
Tanaka K; Fujita N; Higashi Y; Ogawa N
Neurosci Lett; 2002 Sep; 330(2):147-50. PubMed ID: 12231433
[TBL] [Abstract][Full Text] [Related]
28. Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes.
Sinars CR; Cheung-Flynn J; Rimerman RA; Scammell JG; Smith DF; Clardy J
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):868-73. PubMed ID: 12538866
[TBL] [Abstract][Full Text] [Related]
29. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.
Bell A; Wernli B; Franklin RM
Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696
[TBL] [Abstract][Full Text] [Related]
30. The antimalarial action of FK506 and rapamycin: evidence for a direct effect on FK506-binding protein PfFKBP35.
Monaghan P; Leneghan DB; Shaw W; Bell A
Parasitology; 2017 Jun; 144(7):869-876. PubMed ID: 28274284
[TBL] [Abstract][Full Text] [Related]
31. Changes in peptidyl-prolyl cis/trans isomerase activity and FK506 binding protein expression following neuroprotection by FK506 in the ischemic rat brain.
Brecht S; Schwarze K; Waetzig V; Christner C; Heiland S; Fischer G; Sartor K; Herdegen T
Neuroscience; 2003; 120(4):1037-48. PubMed ID: 12927209
[TBL] [Abstract][Full Text] [Related]
32. The emerging importance of immunophilins in fibrosis development.
Alqudah A; AbuDalo R; Qnais E; Wedyan M; Oqal M; McClements L
Mol Cell Biochem; 2023 Jun; 478(6):1281-1291. PubMed ID: 36302992
[TBL] [Abstract][Full Text] [Related]
33. FAP48, a new protein that forms specific complexes with both immunophilins FKBP59 and FKBP12. Prevention by the immunosuppressant drugs FK506 and rapamycin.
Chambraud B; Radanyi C; Camonis JH; Shazand K; Rajkowski K; Baulieu EE
J Biol Chem; 1996 Dec; 271(51):32923-9. PubMed ID: 8955134
[TBL] [Abstract][Full Text] [Related]
34. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells.
Fruman DA; Wood MA; Gjertson CK; Katz HR; Burakoff SJ; Bierer BE
Eur J Immunol; 1995 Feb; 25(2):563-71. PubMed ID: 7533090
[TBL] [Abstract][Full Text] [Related]
35. FKBPs in bacterial infections.
Ünal CM; Steinert M
Biochim Biophys Acta; 2015 Oct; 1850(10):2096-102. PubMed ID: 25529296
[TBL] [Abstract][Full Text] [Related]
36. FKBP51 regulation of AKT/protein kinase B phosphorylation.
Wang L
Curr Opin Pharmacol; 2011 Aug; 11(4):360-4. PubMed ID: 21498116
[TBL] [Abstract][Full Text] [Related]
37. Neural roles of immunophilins and their ligands.
Sabatini DM; Lai MM; Snyder SH
Mol Neurobiol; 1997 Oct; 15(2):223-39. PubMed ID: 9396011
[TBL] [Abstract][Full Text] [Related]
38. Time-dependent inhibition of peptidylprolyl cis-trans-isomerases by FK506 is probably due to cis-trans isomerization of the inhibitor's imide bond.
Zarnt T; Lang K; Burtscher H; Fischer G
Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):159-64. PubMed ID: 7529995
[TBL] [Abstract][Full Text] [Related]
39. The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.
Dumont FJ; Staruch MJ; Koprak SL; Siekierka JJ; Lin CS; Harrison R; Sewell T; Kindt VM; Beattie TR; Wyvratt M
J Exp Med; 1992 Sep; 176(3):751-60. PubMed ID: 1380976
[TBL] [Abstract][Full Text] [Related]
40. FK506-binding protein-type peptidyl-prolyl cis-trans isomerase from a halophilic archaeum, Halobacterium cutirubrum.
Iida T; Iwabuchi T; Ideno A; Suzuki S; Maruyama T
Gene; 2000 Oct; 256(1-2):319-26. PubMed ID: 11054562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
